In this study, we successfully knocked out the CHML gene in liver cancer cells using CRISPR-Cas9 technology and found, consistent with previous reports, no effect on the proliferation of HCC cells or their in vivo tumour growth rate. The gene discussed is CHML; the disease is liver cancer.